V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009599 | 310004867 | 1.6 | 61.9 | null | 2016-04-02 | 2016-04-29 | Cisplatin 100 + RT(H&N) 1 day | Y | Y | 310019145 | CISPLATIN + RT |
| 310009600 | 310004868 | 1.69 | null | Curative (C) | 2017-09-30 | 2018-10-04 | Cyclophosphamide High Dose | Y | N | 310019151 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009601 | 310008099 | 1.73 | 96 | null | 2013-01-25 | 2013-11-11 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019167 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009602 | 310004870 | 1.75 | 66 | Palliative (P) | 2014-05-12 | 2016-01-08 | Docetaxel 75mg/m2 (21 day) | 2 | N | 310019175 | DOCETAXEL |
| 310009603 | 310008101 | 1.7 | 62.3 | Curative (C) | 2014-03-19 | 2014-03-20 | Ipilimumab | N | N | 310019192 | IPILIMUMAB |
| 310009604 | 310004874 | 1.58 | 50 | Palliative (P) | 2015-03-06 | 2015-03-12 | Bexarotene | N | N | 310019214 | ESHAP |
| 310009605 | 310008102 | null | 64.2 | Adjuvant (A) | 2018-04-25 | 2018-06-09 | ESHAP | N | null | 310019216 | ESHAP |
| 310009606 | 310004878 | 1.82 | null | Palliative (P) | 2016-07-17 | 2016-07-19 | Carboplatin + Etoposide iv&po | N | null | 310019225 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009607 | 310004880 | 1.6 | 58.4 | Palliative (P) | 2013-12-25 | 2014-01-17 | Cisplatin | null | null | 310019231 | CISPLATIN |
| 310009608 | 310004884 | 1.74 | 108 | Curative (C) | 2014-07-14 | 2014-10-13 | Methotrexate intrathecal | 02 | N | 310019236 | METHOTREXATE INTRATHECAL |
| 310009611 | 310008108 | 1.57 | 63 | Curative (C) | 2016-06-07 | 2016-06-16 | Ipilimumab | 02 | N | 310019275 | IPILIMUMAB |
| 310009612 | 310004895 | 1.8 | 62 | Palliative (P) | 2014-02-27 | 2014-02-27 | Rituximab | N | N | 310019289 | RITUXIMAB |
| 310009613 | 310004895 | 0 | 60.4 | Palliative (P) | 2016-10-01 | 2016-10-01 | CHOP R - 21 days | null | N | 310019289 | CHOP R |
| 310009615 | 310004899 | null | 52.4 | Curative (C) | 2015-09-24 | 2015-09-30 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 310019331 | CISPLATIN + RT |
| 310009616 | 310004901 | 1.71 | 105.6 | Curative (C) | 2013-06-19 | 2015-07-31 | Methotrexate intrathecal | 02 | N | 310019334 | METHOTREXATE INTRATHECAL |
| 310009617 | 310004903 | 1.62 | 65.699 | Palliative (P) | 2014-10-08 | 2015-06-25 | CHOP R - 21 days | N | N | 310019339 | CHOP R |
| 310009618 | 310008114 | 1.55 | 58.25 | Curative (C) | 2016-08-03 | 2017-02-11 | Ipilimumab | N | N | 310019349 | IPILIMUMAB |
| 310009619 | 310008115 | 1.73 | 47.3 | Palliative (P) | null | 2017-01-25 | Methotrexate intrathecal | N | N | 310019357 | METHOTREXATE INTRATHECAL |
| 310009620 | 310004907 | 1.84 | 61 | null | 2016-02-23 | 2016-03-08 | Rituximab | N | N | 310019360 | RITUXIMAB |
| 310009621 | 310004908 | 1.58 | 41.4 | Palliative (P) | 2017-07-01 | 2017-12-04 | Cyclophosphamide oral | N | null | 310019361 | CYCLOPHOSPHAMIDE |
| 310009622 | 310004909 | 1.85 | 82 | Not known (9) | 2014-10-17 | 2015-09-13 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019366 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009623 | 310004912 | 1.81 | 88.2 | Palliative (P) | 2013-09-01 | 2013-09-09 | CYCLOPHOSPHAMIDE | Y | N | 310019371 | CYCLOPHOSPHAMIDE |
| 310009624 | 310004914 | 1.7 | 94.1 | Not known (9) | 2016-10-15 | 2016-10-18 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | 310019376 | UKALL2011 |
| 310009625 | 310004916 | 1.77 | null | Palliative (P) | 2014-03-04 | 2014-04-14 | Ipilimumab | N | N | 310019380 | IPILIMUMAB |
| 310009626 | 310008124 | null | null | Palliative (P) | 2015-10-13 | 2016-03-24 | CHOP R - 21 days | 02 | N | 310019384 | CHOP R |
| 310009627 | 310008125 | 1.5 | null | Palliative (P) | 2016-05-02 | 2016-05-29 | Ipilimumab | N | null | 310019388 | IPILIMUMAB |
| 310009628 | 310004923 | 1.6 | 79.4 | Disease modification (D) | 2017-01-07 | 2017-01-08 | Cyclophosphamide High Dose | N | N | 310019399 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310009629 | 310004925 | 1.85 | 78 | Palliative (P) | 2016-11-10 | 2016-11-12 | Docetaxel 75mg/m2 (21 day) | N | N | 310019415 | DOCETAXEL |
| 310009630 | 310009826 | 1.78 | 56.2 | Palliative (P) | null | 2015-11-02 | Docetaxel 100mg/m2 (21 day) | N | N | 310019422 | DOCETAXEL |
| 310009631 | 310004928 | null | 63.4 | Neo-adjuvant (N) | null | 2015-01-08 | Docetaxel + Gemcitabine with GCSF | N | N | 310019427 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310009632 | 310004929 | 1.52 | 69.9 | Disease modification (D) | 2015-03-01 | 2015-03-17 | Rituximab | N | N | 310019427 | RITUXIMAB |
| 310009633 | 310008131 | null | 93.6 | null | null | 2016-12-09 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 310019432 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310009634 | 310011732 | null | 64.5 | null | 2015-09-20 | 2015-09-22 | Etoposide IV | 2 | null | 310019449 | ETOPOSIDE |
| 310009635 | 310004931 | 1.58 | 51.2 | Curative (C) | 2015-11-06 | 2016-01-03 | Methotrexate intrathecal | 2 | N | 310019457 | METHOTREXATE INTRATHECAL |
| 310009636 | 310004935 | null | 71.2 | Curative (C) | 2013-09-11 | 2013-10-21 | Ipilimumab | N | Y | 310019462 | IPILIMUMAB |
| 310009637 | 310008134 | 1.57 | 73.8 | Curative (C) | 2013-12-18 | 2013-12-19 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 310019463 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009638 | 310004938 | 1.7 | 77.7 | Palliative (P) | 2013-06-27 | 2013-07-26 | Cisplatin + Radiotherapy | null | null | 310019464 | CISPLATIN + RT |
| 310009639 | 310004940 | null | 57.6 | Curative (C) | 2014-06-30 | 2015-09-02 | CYCLOPHOSPHAMIDE | N | N | 310019466 | CYCLOPHOSPHAMIDE |
| 310009640 | 310004943 | null | 80.2 | Palliative (P) | 2015-03-16 | 2015-03-16 | Cisplatin | N | N | 310019467 | CISPLATIN |
| 310009641 | 310004945 | 1.52 | 57 | null | null | 2015-05-13 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019473 | DOCETAXEL + GEMCITABINE |
| 310009642 | 310004949 | 1.79 | 92.9 | Adjuvant (A) | 2012-11-22 | 2013-06-20 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310019476 | CISPLATIN + RT |
| 310009643 | 310008140 | 1.78 | 76.8 | Curative (C) | 2017-09-22 | 2017-10-12 | Docetaxel + Gemcitabine (prior RT) | N | N | 310019477 | DOCETAXEL + GEMCITABINE |
| 310009644 | 310004954 | 1.88 | 77.7 | Palliative (P) | 2011-12-19 | 2013-11-05 | Methotrexate intrathecal | N | N | 310019484 | METHOTREXATE INTRATHECAL |
| 310009645 | 310009830 | null | 54.9 | Palliative (P) | 2016-02-22 | 2016-02-22 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | null | 310019484 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310009646 | 310004955 | null | 67.3 | Palliative (P) | 2014-03-24 | 2017-09-02 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | 310019507 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310009647 | 310008145 | 1.89 | 58.7 | Curative (C) | 2017-02-24 | 2017-03-09 | Methotrexate intrathecal | 2 | N | 310019511 | METHOTREXATE INTRATHECAL |
| 310009648 | 310004961 | 1.79 | 79 | Curative (C) | 2016-06-23 | 2017-02-11 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 99 | N | 310019539 | DOCETAXEL + GEMCITABINE |
| 310009649 | 310004962 | 1.56 | 51 | Palliative (P) | 2014-05-15 | 2014-05-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310019539 | BEXAROTENE |
| 310009651 | 310008151 | 1.81 | 68.3 | Palliative (P) | 2017-12-16 | 2017-12-22 | Ipilimumab | 02 | N | 310019545 | IPILIMUMAB |
| 310009652 | 310004966 | 1.6 | 52.3 | Palliative (P) | 2016-09-12 | 2016-12-20 | Cyclophosphamide oral | N | N | 310019546 | CYCLOPHOSPHAMIDE |